Pancreatic Cancer Research

ResearcherBaylor College of MedicineActive in the last 2 years

Kuldeep Singh Attri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-0668-5245; OpenAlex author ID A5014183306. Sources: OpenAlex.

Their work

Papers
11 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
41
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 3 papers

Papers 11

  1. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. First author DOI 10.1038/s41556-024-01372-4↗
  2. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 … First author DOI 10.1038/s41556-024-01417-8↗
  3. The MUC1-HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling. First author DOI 10.1073/pnas.2315509121↗
  4. PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/ijms24087304↗
  5. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis. Co-author DOI 10.1038/s41388-021-02132-6↗
  6. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Co-author DOI 10.1053/j.gastro.2021.06.045↗
  7. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia. Co-author DOI 10.1016/j.canlet.2020.04.017↗
  8. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia. Co-author DOI 10.1016/j.canlet.2020.07.025↗
  9. Evaluation of Macrophage Polarization in Pancreatic Cancer Microenvironment Under Hypoxia. Co-author DOI 10.1007/978-1-4939-7665-2_23↗
  10. Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics. First author DOI 10.3389/fphys.2018.00335↗
  11. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2017.06.004↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Divya Murthy · 9 shared papers, 2017–2024 · strength 1.36
  2. Pankaj Kumar Singh · 10 shared papers, 2017–2024 · strength 1.21
  3. Surendra Kumar Shukla · 8 shared papers, 2017–2024 · strength 0.94
  4. Kamiya Mehla · 7 shared papers, 2017–2024 · strength 0.83
  5. Ryan J. King · 7 shared papers, 2017–2024 · strength 0.75
  6. Michael Anthony Hollingsworth · 6 shared papers, 2017–2024 · strength 0.73
  7. Nina V. Chaika · 6 shared papers, 2017–2024 · strength 0.71
  8. Ravi Kumar Thakur · 5 shared papers, 2021–2024 · strength 0.67
  9. Aneesha Dasgupta · 6 shared papers, 2017–2024 · strength 0.66
  10. Scott E. Mulder · 5 shared papers, 2020–2024 · strength 0.60
  11. Paul M. Grandgenett · 5 shared papers, 2017–2024 · strength 0.55
  12. Chunbo He · 4 shared papers, 2021–2024 · strength 0.48
  13. Tuo Hu · 3 shared papers, 2021–2024 · strength 0.36
  14. Enza Vernucci · 4 shared papers, 2017–2022 · strength 0.36
  15. Robert Powers · 3 shared papers, 2017–2024 · strength 0.32
  16. Teklab Gebregiworgis · 3 shared papers, 2017–2024 · strength 0.32
  17. Jaime Abrego · 3 shared papers, 2017–2022 · strength 0.28
  18. Rosa F. Hwang · 2 shared papers, 2024 · strength 0.28
  19. Ajay Jain · 2 shared papers, 2024 · strength 0.28
  20. Vikrant Rai · 2 shared papers, 2024 · strength 0.28
  21. Joshua J. Souchek · 2 shared papers, 2024 · strength 0.28
  22. Sai Sundeep Kollala · 2 shared papers, 2024 · strength 0.28
  23. Barish H. Edil · 2 shared papers, 2024 · strength 0.28
  24. Kathryn Elaine Wellen · 2 shared papers, 2024 · strength 0.28
  25. Amarnath (Amar) Natarajan · 2 shared papers, 2024 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.